PRESS-RELEASE ·Filed Jul 16, 2026

ARGX

argenx SE
NEUTRAL
Impact 2/10
Horizonimmediate Processed2mo ago WireGlobeNewswire
Press release: earnings
Actionable Insight • Neutral

This is a routine event scheduling announcement. The Q1 2026 financial data was already released on May 7, 2026. No immediate trading action is warranted. Monitor the actual half-year 2026 results on July 23 for potential catalysts.

DirectionNeutral
Confidencehigh
Horizonimmediate
Latest settled — T+20d
ARGX ▼ -0.12% at T+20d
NEUTRAL call ✗ call lost -0.12% · α vs SPY -3.74% · entry $857.97 → $856.94
Next anchor: T+60d in 7d
Latest observation: T+52 +9.77% FF3 residual α
Entry anchored
Jul 15, 03:59 PM ET
via exchange tick
T+1d
+0.30%
call +0.30% · α +1.29%
$860.55
settled 3mo ago
T+5d
+7.77%
call +7.77% · α +9.44%
$924.60
settled 2mo ago
T+20d
-0.12%
call -0.12% · α -3.74%
$856.94
settled 7w ago
T+60d
—
call — · α —
—
in 7d

Price Chart

Loading chart...

Executive Summary

The filing is a press release announcing the upcoming half-year 2026 earnings conference call. The Q1 2026 financial data provided shows a modest EPS beat of 2.3% against consensus, but this is historical information from a prior quarter, and the filing itself is a routine scheduling announcement with no new material financial disclosure.

Key Financial Metrics

EPS
$5.52
est $5.39 · +2.4%
Rating
in line

Key Facts

  • EPS of $5.52 beat consensus of $5.39 by 2.3%
  • Revenue data not included in the filing
  • Conference call scheduled for July 23, 2026 to discuss half-year 2026 results

Financial Impact

No material financial impact; the filing is a routine announcement of a future earnings call and does not contain new financial information.

Risk Factors

  • No specific risks identified in this filing

Market Snapshot

Exchange
Nasdaq
Sector
Biological Products, (No Diagnostic Substances)
Analyst Consensus
92% bullish (25 analysts)

Investment Themes

Biotech & Drug Discovery

Documents Analyzed

This report is based on 1 press release from GlobeNewswire.

DocumentAccession Number
PRESS-RELEASE Data (Synthetic)press-3328217
14 reports for ARGX
Performance horizon
100% Hit rate 8 of 8 directional calls best @ T+60▲ +30.22%Jun 3, 2026
Filters
Rows
Reports for ARGX — sortable, filterable
TypeNow
Sep 10, 2026
22d ago
Institutional Cluster
MIXED ★ 5/10
$984.04 $995.77▲ +1.19%▲ +1.69%$918.23 (−6.69%)
Aug 17, 2026
6w ago
6-K
BULLISH ★ 8/10
$987.84 $1,011.11▲ +2.36%▲ +3.55%$918.23 (−7.05%)
Aug 6, 2026
8w ago
Press Release
BULLISH ★ 7/10
$875.30 $856.94▼ −2.10%▼ −3.31%$918.23 (+4.91%)
Jul 27, 2026
9w ago
6-K
BULLISH ★ 7/10
$888.82 $853.82▼ −3.94%▼ −5.01%$918.23 (+3.31%)
Jul 27, 2026
9w ago
Press Release
BULLISH ★ 7/10
$888.82 $853.82▼ −3.94%▼ −5.01%$918.23 (+3.31%)
Jul 23, 2026
10w ago
Press Release
NEUTRAL ★ 5/10
$924.60 $872.58▼ −5.63%▼ −6.10%$918.23 (−0.69%)
Jul 16, 2026
11w ago
Press Release
NEUTRAL ★ 2/10
$857.97 $924.60▲ +7.77%▲ +9.44%$918.23 (+7.02%)
Jun 23, 2026
14w ago
6-K
NEUTRAL ★ 4/10
$853.40 $912.46▲ +6.92%▲ +5.91%$918.23 (+7.60%)
Jun 3, 2026
17w ago
6-K
BULLISH ★ 5/10
$813.14 $862.18▲ +6.03%▲ +9.85%$918.23 (+12.92%)
May 8, 2026
20w ago
Press Release
BULLISH ★ 7/10
$813.28 $776.26▼ −4.55%▼ −4.47%$918.23 (+12.91%)
Showing 10 of 14

US Market Status

Market Open — Closes in 2h 13m

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access
Report published Jul 16, 2026